Investment case
Codiak BioSciences, Inc.
CDNA · 6 developments mapped · last assessed 2026-09-20
Market Ontology has mapped 6 macro, policy, and market developments to Codiak BioSciences, Inc. since 2026-09-19. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.
Valuation
No validated run has been published for CDNA yet, so no modelled value is shown. The CDNA valuation is in the public catch-up queue.
Subscribers do not wait for the weekly cycle: they run CDNA on demand, against live prices and the latest filings, and change any assumption the developments below move.
Filed financials
Current case
- Open question
Twist Bioscience partners with Eli Lilly on TuneLab AI discovery
Increased competitive pressure in synthetic biology and antibody discovery services, potential for market share shifts.
· Moves market share in synthetic biology tools, pricing power for services
What changed, by assumption
- 2026-09-19Twist Bioscience partners with Eli Lilly on TuneLab AI discovery
- 2026-09-19Twist Bioscience Partners with Eli Lilly on AI Drug Discovery Platform
- 2026-09-19Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform
- 2026-09-20Twist Bioscience shares gain 31% on Eli Lilly AI drug discovery pact
- 2026-09-19Twist Bioscience partners with Eli Lilly on AI-driven TuneLab drug discovery
Event impact log
Full ledger →| Date | Mechanism | Direction | Horizon | Impact |
|---|---|---|---|---|
| 2026-09-20 | Twist Bioscience shares gain 31% on Eli Lilly AI drug discovery pact | watch | 1-3m | 0.20 |
| 2026-09-19 | Twist Bioscience partners with Eli Lilly on TuneLab AI discovery | watch | 1-3m | 0.30 |
| 2026-09-19 | Twist Bioscience partners with Eli Lilly on AI-driven TuneLab drug discovery | watch | 1-3m | 0.20 |
| 2026-09-19 | Twist Bioscience Partners with Eli Lilly on AI Drug Discovery Platform | watch | 1-3m | 0.30 |
| 2026-09-19 | Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform | watch | 3-12m | 0.30 |
| 2026-09-19 | Twist Bioscience Rallies 31% on Eli Lilly AI Drug Discovery Collaboration | watch | 3-12m | 0.20 |